TARS — Tarsus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $3.47bn
- $3.09bn
- $451.36m
U.S. RESEARCH ROUNDUP -ANI Pharmaceuticals, Berkshire Hathaway, Chevron
Tarsus Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tarsus Pharmaceuticals Q2 EPS USD -0.48
Tarsus Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Tarsus Pharmaceuticals Q1 Net Income USD -25.12 Million Vs. IBES Estimate USD -25.1 Million
U.S. STOCKS ON THE MOVE-MeiraGTx, CervoMed, Natgas companies
U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx
U.S. STOCKS ON THE MOVE-Xpeng, D-Wave Quantum, Trinity Biotech
Tarsus Pharma dips after upsized $125 mln stock offering
Brief: Tarsus Announces Pricing Of Upsized $125 Million Public Offering
Tarsus Pharmaceuticals dips on planned $100 million equity raise
Tarsus Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Tarsus Pharmaceuticals Q4 Basic EPS USD -0.6
U.S. RESEARCH ROUNDUP- Airbnb, Post Holdings, Syndax Pharmaceuticals
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Tarsus Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Tarsus Pharmaceuticals Q3 Basic EPS USD -0.61
Brief: Tarsus Welcomes Kate Goodrich, M.D., MHS, To Its Board Of Directors
Tarsus Pharmaceuticals Inc expected to post a loss of 94 cents a share - Earnings Preview